Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Astrazeneca Plc Ord
(OP:
AZNCF
)
174.90
UNCHANGED
Streaming Delayed Price
Updated: 1:32 PM EDT, Aug 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Astrazeneca Plc Ord
< Previous
1
2
3
4
5
6
7
8
Next >
Daiichi Sankyo - AstraZeneca's Enhertu Receives Priority Review In US For Lung Cancer
April 19, 2022
Via
Benzinga
After Encouraging Data, Blueprint Medicines Plans Combination Cohort In Tagrisso Resistant Lung Cancer
April 11, 2022
Blueprint Medicines Corp (NASDAQ: BPMC)
Via
Benzinga
Seagen Wins $42M Patent Claim Against Daiichi In Cancer Drug Case
April 11, 2022
A jury in Marshall, Texas, awarded Seagen Inc (NASDAQ: SGEN)
Via
Benzinga
AstraZeneca Bets $25M On Preclinical Bispecific Antibody
April 07, 2022
Via
Benzinga
FDA Official Says Frequent COVID-19 Booster Shows Not Sustainable: WSJ
April 07, 2022
According to a U.S. health regulator, asking people to get COVID-19 boosters frequently wasn't sustainable because of vaccine fatigue, and authorities needed to develop a long-term strategy for...
Via
Benzinga
AstraZeneca's Imfinzi Flunks In Late-Stage Advanced Cervical Cancer Study
March 24, 2022
Via
Benzinga
AstraZeneca's Ultomiris Shows Sustained Improvements In Functional Activities In Neuromuscular Disease
April 06, 2022
Via
Benzinga
Ionis Pharma - AstraZeneca Antisense Medicine Met Its Primary, Secondary Goals To Lower Cholesterol
April 04, 2022
Ionis Pharmaceuticals Inc (NASDAQ: IONS) and its partner, AstraZeneca Plc (NASDAQ: AZN), have
Via
Benzinga
EMA Recommends Approval Of AstraZeneca's COVID-19 Therapy, Evusheld
March 24, 2022
EMA's human medicines committee (CHMP) has
Via
Benzinga
AstraZeneca's COVID-19 Vaccine Expected To Win European Approval This Week: Reuters
March 23, 2022
European Medicines Agency is expected to approve AstraZeneca Plc's (NASDAQ: AZN) antibody-based COVID-19 vaccine for preventing COVID-19 infections,
Via
Benzinga
Bristol Myers Sues AstraZeneca Over PD-L1 Cancer Drug Patents
March 21, 2022
Bristol Myers Squibb Co (NYSE: BMY) claims that AstraZeneca Plc's (NASDAQ: AZN) PD-L1 inhibitor, Imfinzi, infringed on at least eight patents in a newly filed complaint.
Via
Benzinga
AstraZeneca's COVID-19 Antibody Neutralizes Omicron Sub-variants, Lab Study Shows
March 21, 2022
AstraZeneca Plc's (NASDAQ: AZN) antibody-based cocktail to prevent and treat COVID-19 retained
Via
Benzinga
AstraZeneca Mulls Ditching US Approval For Its COVID-19 Vaccine: FT
March 18, 2022
Citing AstraZeneca Plc's (NASDAQ: AZN) head of research and development, the Financial Times reported that the Company
Via
Benzinga
AstraZeneca Settles Ultomiris-Related Patent Litigation With Chugai
March 17, 2022
Alexion Pharmaceuticals, a unit of AstraZeneca plc (NASDAQ: AZN), has entered into a settlement agreement with Chugai Pharmaceutical Co Ltd, resolving all patent disputes related to Ultomiris...
Via
Benzinga
AstraZeneca's COVID-19 Therapy Approved In Britain As Preventive Option
March 17, 2022
Britain's Medicines and Healthcare products Regulatory Agency (MHRA)
Via
Benzinga
Europe Kickstarts Reviewing AstraZeneca Application For Its COVID Antibody
March 16, 2022
Via
Benzinga
White House Warns It Cannot Afford COVID-19 Related Solutions If Cases Increase: FT
March 16, 2022
The White House says that the U.S. is running out of money to pay for COVID-19 vaccines, tests, and treatments, making it unprepared for any rising cases in the future.
Via
Benzinga
Merck-AstraZeneca Stop Keytruda/Lynparza Combo Trial In Prostate Cancer Patients
March 15, 2022
Merck & Co Inc (NYSE: MRK) will stop the Phase 3 KEYLYNK-010 trial investigating Keytruda combined with Lynparza for metastatic castration-resistant prostate cancer (mCRPC).
Via
Benzinga
FDA Declines To Approve AstraZeneca's Asthma Treatment For Chronic Nasal Condition
March 14, 2022
The FDA has declined to approve AstraZeneca Plc's (NASDAQ: AZN) asthma medicine, Fasenra (benralizumab), to treat chronic rhinosinusitis with nasal polyps, a...
Via
Benzinga
AstraZeneca-Merck's Lynparza Wins FDA Approval For Early-Stage Breast Cancer
March 14, 2022
The FDA has approved AstraZeneca Plc's (NASDAQ: AZN) cancer drug, jointly developed with Merck & Co Inc (NYSE: MRK) to treat patients with early-...
Via
Benzinga
AstraZeneca-Sanofi's Nirsevimab Shows 75% Efficacy Against RSV In Healthy Infants
March 03, 2022
AstraZeneca Plc (NASDAQ: AZN) and Sanofi SA (NASDAQ: SNY) have shared detailed results from the MELODY Phase 3 trial evaluating nirsevimab in respiratory...
Via
Benzinga
AstraZeneca, GSK's COVID-19 Therapies Lose Efficacy Against Omicron's Subvariants
February 25, 2022
The FDA authorized an increased dose in the case of AstraZeneca Plc's (NASDAQ: AZN) pre-exposure prophylaxis drug Evusheld (tixagevimab and cilgavimab)....
Via
Benzinga
Blood Clot Risk After First AstraZeneca COVID-19 Shot Very Small - UK Study Shows
February 23, 2022
A large study into rare blood clots linked with AstraZeneca Plc's (NASDAQ: AZN) COVID-19 vaccine found between one and three cases per million, and only after...
Via
Benzinga
Roche And AstraZeneca Settle Ultomiris Patent Lawsuit
February 22, 2022
Roche Holdings AG (OTC: RHHBY) has decided to close out a patent infringement lawsuit against AstraZeneca plc (NASDAQ: AZN), centering around the latter's newly...
Via
Benzinga
AstraZeneca's Enhertu Meets Primary Endpoint In HER2-Low Breast Cancer Setting
February 22, 2022
AstraZeneca plc (NASDAQ: AZN) said that Enhertu prolonged survival and slowed the progression of metastatic breast cancer with low levels of a protein known as HER2...
Via
Benzinga
GSK Halts Late-Stage RSV Vaccine Trial In Pregnant Women
February 18, 2022
GlaxoSmithKline plc (NYSE: GSK) has paused a late-stage trial of its respiratory syncytial virus (RSV) vaccine candidate in pregnant women based on safety...
Via
Benzinga
Short Shelf Life Of AstraZeneca's COVID-19 Shot Entangles Vaccine Rollout In Poorer Nations: Reuters
February 16, 2022
According to officials and internal World Health Organization documents reviewed by Reuters, the relatively short shelf life of AstraZeneca Plc's (NASDAQ: AZN)...
Via
Benzinga
Why Are AstraZeneca Shares Trading Higher Today
February 15, 2022
Adding AstraZeneca Plc's (NASDAQ: AZN) Lynparza to Johnson & Johnson's (NYSE: JNJ) Zytiga (abiraterone) extended the time to live without disease...
Via
Benzinga
AstraZeneca Records Bumper COVID-19 Vaccine Sales Of ~$4B In FY21
February 10, 2022
AstraZeneca Plc's (NASDAQ: AZN) total revenue jumped 63% Y/Y to $12.0
Via
Benzinga
AstraZeneca Dumps Off Mid-Stage Cardiovascular Drug To Regio Biosciences
February 03, 2022
AstraZeneca plc (NASDAQ: AZN) has granted
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.